Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02629731 · ClinicalTrials.gov registry record · NA

Orthotic Dose Response Study

A NA study of Ankle Osteoarthritis and Flat Foot or Pes Planus, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
35
Enrollment target
2
Study locations

NCT02629731 is a NA study of Ankle Osteoarthritis and Flat Foot or Pes Planus that has completed, run by VA Office of Research and Development. The registered enrollment target is 35 participants. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02629731, a NA study of Ankle Osteoarthritis and Flat Foot or Pes Planus, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
2
Study locations

Study Summary

This study will investigate the effect of foot orthoses on two common conditions (ankle osteoarthritis and symptomatic adult onset flat feet) by using a custom biplane X-ray system the group has developed to very accurately and precisely quantify foot bone motion. The investigators will vary the design of the orthoses and subjects will be examined to find out which are most effective at improving function.

Interventions

  • DEVICE custom orthoses with varying degrees of hindfoot posting

Study Locations (2)

Washington

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle
  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2016-07-01
Est. Completion 2023-12-29
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT02629731

The ClinicalTrials.gov registry entry for NCT02629731 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Ankle Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which custom orthoses with varying degrees of hindfoot posting is the first listed.

NCT02629731 reports 2 study locations spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT02629731 about?

NCT02629731 is a clinical study titled "Orthotic Dose Response Study". This study will investigate the effect of foot orthoses on two common conditions (ankle osteoarthritis and symptomatic adult onset flat feet) by using a custom biplane X-ray system the group has developed to very accurately and precisely quantify foot bone motion. The investigators will vary the des...

What is the current status of trial NCT02629731?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-07-01. Estimated completion is 2023-12-29.

What conditions does trial NCT02629731 study?

This clinical trial studies the following conditions: Ankle Osteoarthritis, Flat Foot or Pes Planus.

What interventions are being tested in trial NCT02629731?

The interventions under investigation include: custom orthoses with varying degrees of hindfoot posting (DEVICE).

Who is sponsoring clinical trial NCT02629731?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02629731 being conducted?

This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ankle Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.